BSE filing, NSE: NAGREEKEXP. Summary written from the filing by ALFA Finder's alert engine.
Nagreeka Exports Ltd: key numbers
- Share price
- ₹20.91
- Market cap
- ₹65.34 Cr
- Revenue (annual)
- ₹511.2 Cr
- Net profit (annual)
- ₹3.06 Cr
- P/E (TTM)
- 20.6×Sector 49.5×
- Promoter holding
- 57.32%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nagreeka Exports Ltd
All →Nagreeka Exports Annual General Meeting
Nagreeka Exports Ltd held its 37th Annual General Meeting on 29th September 2026, transacting business including director re-appointments and cost auditor ratification.
Nagreeka Exports Annual Report
Nagreeka Exports submitted a revised Annual Report for FY 2025-26 to rectify a clerical error in the 'Details of promoters shareholding' section of the original report.
Nagreeka Exports Annual General Meeting
Nagreeka Exports Limited issued the notice for its 37th Annual General Meeting to be held on September 29, 2026. The meeting covers financial statement adoption.
Nagreeka Exports Q1 FY27 Results: Net Profit ₹1 Cr, Up 11.1% YoY
Nagreeka Exports Ltd reported revenue from operations of ₹173.8 Cr (+92.5% YoY) and net profit of ₹1 Cr (+11.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1 Cr · +11.1% YoY
Nagreeka Exports Board Meeting Outcome
Nagreeka Exports announced its board meeting outcome, approving unaudited financial results for Q1 FY27 and re-appointing two directors to the company board.
Nagreeka Exports Board Meeting Date
Nagreeka Exports Ltd scheduled a Board Meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.